FDI World Dental Federation calls for global leaders to prioritise action against oral diseases at major UN meeting on health / Call issued on World Oral Health Day, as data shows oral diseases impact nearly half the world's population
plus
Actualités sur Santè / Médecine
The Adecco Group 2022 Annual Report
Zurich (ots/PRNewswire) - AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange The Adecco Group 2022 Annual Report is now available in the Ad Hoc section of the Group's website. Please also refer to the dedicated Annual Report section. 2022 Annual Report (PDF) Financial calendar - AGM 12 April 2023 - Ex-Dividend date 18 April 2023 - Q1 2023 Results 4 May 2023 - Q2 2023 / Half Year 2023 Results 3 ...
plusREVEAL GENOMICS®´ BREAKTHROUGH TECHNOLOGY ENTERS THE LIQUID BIOPSY FIELD IN ONCOLOGY
Barcelona, Spain (ots/PRNewswire) - - REVEAL GENOMICS®´ machine learning-based technology applied to ctDNA was able to predict drug response and survival outcome in patients with metastatic breast cancer treated with endocrine therapy and CDK4/6 inhibitors. - This new approach provides multi-feature genomic predictors from ctDNA for breast cancer and other types of ...
plusMedison Pharma; Alnylam Pharmaceuticals
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
Zug, Switzerland (ots/PRNewswire) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their ...
plusIktos raises € 15.5m Series A round to expand its artificial intelligence-based drug discovery technologies and solutions
Paris, France and Lausanne Switzerland (ots) - ● The round is co-led by M Ventures and Debiopharm Innovation Fund with Omnes Capital; all joining as new investors ● Series A will enable Iktos to expand its AI technology platform and launch Iktos Robotics; an AI-driven automated end-to-end drug discovery service ...
plusServier Announces Partnership with QIAGEN to Develop New mIDH1 Companion Diagnostic Test to Support Servier's Onco-hematology Portfolio
Paris (ots/PRNewswire) - Servier, a global pharmaceutical group, today announced it has entered into a strategic partnership with QIAGEN, a leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life, to develop ...
plusHovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise
Lisbon, Portugal (ots/PRNewswire) - Hovione, the leader in spray drying and particle engineering, won the 2023 CDMO Leadership Award across all six categories – capability, compatibility, expertise, quality, reliability and service across all three groups of respondents (Big Pharma, Small Pharma, and Overall ...
plusDEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Lausanne, Switzerland (ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having ...
plusServier receives a positive CHMP opinion for Tibsovo® in IDH1-mutated Acute Myeloid Leukemia (AML) and Cholangiocarcinoma (CCA) patients
Paris (ots/PRNewswire) - - Tibsovo® (ivosidenib tablets) is the first IDH1 inhibitor recommended for approval in Europe - The positive CHMP opinion is based on clinical data from the AGILE (in AML) and ClarIDHy (in CCA) studies Servier, a global pharmaceutical company, today announced that the Committee for ...
plusNew study from Waltham Petcare Science Institute, part of Mars Petcare, shows cannabidiol (CBD) is effective at reducing stress in dog
WALTHAM-ON-THE-WOLDS, England (ots/PRNewswire) - - Single dose of THC-free CBD reduced stress in healthy dogs - The study, conducted by the Waltham Petcare Science Institute, was published today in Frontiers in Veterinary Science. Results from a study performed by the Waltham Petcare Science Institute published ...
plusTurkey-Syria Earthquake: Online aid marketplace launched to speed up critical minutes of aid response
London (ots/PRNewswire) - As the death toll in Turkey reaches 36,000, online aid marketplace 'Respondlocal' is launching in Turkey to speed up the aid response. The online platform, launched by tech start-up NeedsList in collaboration with Google.org, encourages local partners to post their needs and match with ...
plusSyqe Medical Announces Agreement with Israeli Ministry of Defence to Provide the SyqeAir Technology to Veterans
Tel Aviv, Israel (ots/PRNewswire) - Syqe Medical, the developer of innovative technologies in the world of medical devices, is pleased to announce the signing of an agreement with the Israeli Ministry of Defence to supply the SyqeAir Inhaler and Cartridges to all veterans prescribed medical cannabis by inhalation ...
plusGENERATIVE AI SOLUTIONS CORP. (formerly Idle Lifestyle Inc.) Announces Change of Name and Effective Date For Share Consolidation and Provides Updated on Potential Transaction
Vancouver, Bc (ots/PRNewswire) - GENERATIVE AI SOLUTIONS CORP. (formerly Idle Lifestyle Solutions Inc.). (the "Company") (CSE: IDLE.X) (FSE: 99L.F) (OTC: IDLSF) is pleased to announce that it has changed its name from "Idle Lifestyle Inc." to "Generative AI Solutions Corp." to reflect its intended strategic ...
plusHuma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease
London (ots/PRNewswire) - - Aim is to prevent avoidable heart attacks and strokes in North London - Expands primary care capacity by utilising digital tools to identify and manage high risk individuals - Advances proactive, predictive care for people at risk of the world's leading cause of death1 Huma Therapeutics ...
plusAccord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer
London (ots/PRNewswire) - Accord Healthcare (Accord), one of Europe's fastest growing pharmaceutical companies, marks World Cancer Day 2023 today by taking part in news-style programme for ITN Business alongside other partners from industry and the patient community to raise awareness of the importance of working ...
plusServier full year 2021/22 results confirm the transformation trajectory of the Group
Paris (ots/PRNewswire) - - Consolidated sales revenue of €4.876 billion, up 9.8% (+6.6% at CERi), driven by strong growth in international sales - Sales revenue for brand-name medicines reached €3.694 billion, up 12.5% (+8.9% at CERi), and €1.182 billion for generics, up 2.0% (stable at CERi) - Important developments in oncology to address high unmet medical ...
plusBayer Partners with Huma on Bayer® Aspirin Heart Risk Assessment Online Educational Tool to Raise Awareness of Heart Health and its Risk Factors
New York (ots/PRNewswire) - Huma's predictive algorithm will power a new global online patient engagement tool* that provides an accessible solution for heart health education Huma Therapeutics Limited ("Huma"), a leading global digital health company, and Bayer, a leading global life sciences company, have ...
plusSchweizerische Multiple Sklerose Gesellschaft
2Swiss Multiple Sclerosis Society awards first MS research prize
plusChiesi appoints Giuseppe Accogli as new Group CEO
Parma, Italy (ots/PRNewswire) - - Giuseppe Accogli is a successful Executive Leader with 25 years of international experience in the Med-tech sector of reputed and complex companies such as Tyco Healthcare (Covidien), Baxter and Medtronic - "As CEO, I strive to enable our leaders, people and partners to achieve even greater success in fulfilling the commitment to be a sustainable force for good in the biopharmaceutical ...
plusPlumCare RWE partners with Lifebit on Greece's newborn genomic sequencing program, BeginNGS
London (ots/PRNewswire) - - PlumCare RWE and Lifebit enter a three-year partnership to support Greece's pioneering national newborn genomic sequencing program, BeginNGS. - Researchers will be able to access and analyse data securely in combination with global cohorts, whilst ensuring data is kept safe, private and in place in their secure environment using Lifebit's ...
plusACCEPTANCE PERIOD FOR EXCHANGE OFFER EXTENDED PENDING COMPETITION CLEARANCES
Kaiseraugst, Switzerland, Heerlen, Netherlands and Geneva (ots/PRNewswire) - THIS PRESS RELEASE IS NOT FOR GENERAL RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO, DIRECTLY OR INDIRECTLY, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR REGULATIONS This is a joint press ...
plusEagle Genomics' Scale-Up Funding from OMRON Ventures to Drive Sustainability Innovation in Microbiome R&D
Cambridge, England (ots/PRNewswire) - - OMRON Ventures joins existing investors abrdn, Environmental Technologies Fund and consortium led by Granpool Innovative Investments - Scale-up focused on enabling novel, sustainable scientific innovations that harness the microbiome to solve for 'One Health' challenges, ...
plusLargest decentralised study of its kind shows high levels of engagement with Huma's study app
London (ots/PRNewswire) - - More than 90% of 2,524 participants invited to join a fully virtual COVID-19 study, run by Cambridge researchers, downloaded and registered on the study app1 - Around 75% of participants completed digital biomarker assessments such as resting heart rate, temperature and oxygen saturation at least once per week1 - Participants were aged 45 - ...
plusDEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS
Lausanne, Switzerland (ots/PRNewswire) - - Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment. - Debiopharm is developing Debio 4126, a ...
plusDEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS
Lausanne, Switzerland (ots) - - Acromegaly and gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare diseases that require life-long chronic treatment. Monthly somatostatin analog (SSA) injections are the standard of care as first-line medical treatment. - Debiopharm is developing Debio 4126, a novel ...
plusMars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care
New York (ots/PRNewswire) - - The genome database will power ongoing scientific efforts worldwide and help advance individualized pet health care - Insights from this partnership will feed into the MARS PETCARE BIOBANK™, a longitudinal study to understand pet health and disease, transforming pet care for future ...
plusSarah Otten Joins Medison Pharma as VP, GM Americas Region
Petach Tikvah, Israel and Zug, Switzerland (ots/PRNewswire) - Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets ("Medison"), is proud to announce the joining of Sarah ...
plusHuma to provide best-in-class digital clinical trials solutions through landmark acquisition of Alcedis
London and Frankfurt, Germany (ots/PRNewswire) - - Acquisition combines award-winning digital health platform with global clinical research expertise acquired over 25 years - Creates new and advanced digital solutions across all phases of clinical trials - Accelerates patient recruitment and the development of new ...
plusSanisure Announces the Acquisition of a Leading Silicone Extrusion Facility in Twinsburg, Ohio
Camarillo, Calif. (ots/PRNewswire) - Sanisure, a leading, vertically-integrated player in the single- use bioprocessing technology space, is pleased to announce the acquisition of Medical Elastomer Development, Inc ("MED") a silicone extrusion facility from Q Holding, a 3i portfolio company. This state-of-the-art facility located in Twinsburg, Ohio, serves many ...
plusThe Department of Health - Abu Dhabi
AstraZenca, G42 Healthcare enter strategic partnership to manufacture pharmaceutical products in Abu Dhabi
Abu Dhabi, Uae (ots/PRNewswire) - Building on the ongoing efforts of the Department of Health – Abu Dhabi (DoH) in spearheading Abu Dhabi's healthcare ecosystem, AstraZeneca, a science-led biopharmaceutical and one of the top 10 biopharma companies globally, and G42 Healthcare, an AI-powered healthcare company, ...
plus
Précédent12345678910Suivant